Administration of breast milk cell fractions to neonates with birthweight equal to or less than 1800 g: a randomized controlled trial.
Breast milk cell
Breastfeeding
Neonatal mortality
Neonate
Preterm infants
Journal
International breastfeeding journal
ISSN: 1746-4358
Titre abrégé: Int Breastfeed J
Pays: England
ID NLM: 101251562
Informations de publication
Date de publication:
23 08 2021
23 08 2021
Historique:
received:
06
12
2020
accepted:
27
07
2021
entrez:
24
8
2021
pubmed:
25
8
2021
medline:
26
10
2021
Statut:
epublish
Résumé
Most premature and very low birthweight infants cannot tolerate breast milk feeding in the first few days of life and are deprived of its benefits. This study evaluates the clinical outcomes of administering breast milk cell fractions to neonates with a birthweight of ≤1800 g. We conducted a randomized controlled trial on 156 infants in the neonatal intensive care unit of Mahdieh Maternity Hospital in Tehran, Iran, from May 2019 to April 2020. All neonates with a birthweight ≤1800 g were enrolled and divided into intervention and control groups using stratified block randomization. Neonates in the intervention group received the extracted breast milk cell fractions (BMCFs) of their own mother's milk after being centrifuged in the first 6 to 12 h after birth. The control group received routine care, and breastfeeding was started as soon as tolerated in both groups. Study outcomes were necrotizing enterocolitis (NEC), death, and in-hospital complications. We divided participants into two groups: 75 neonates in the intervention group and 81 neonates in the control group. The mean birthweight of neonates was 1390.1 ± 314.4 g, and 19 (12.2%) neonates deceased during their in-hospital stay. The incidence of NEC was similar in both groups. After adjustment for possible confounders in the multivariable model, receiving BMCFs were independently associated with lower in-hospital mortality (5 [26.3%] vs. 70 (51.1%]; odds ratio (OR): 0.24; 95% confidence interval [CI] 0.07, 0.86). Also, in a subgroup analysis of neonates with birthweight less than 1500 g, in-hospital mortality was significantly lower in the intervention group (4 [9.5%] vs. 13 [30.2%]; OR: 0.24; 95% CI 0.07, 0.82). There were no differences in major complications such as bronchopulmonary dysplasia and retinopathy of prematurity between the two groups. No adverse effects occurred. Our research demonstrated a significantly lower mortality rate in neonates (with a birthweight of ≤1800 g) who received breast milk cell fractions on the first day of life. Since this is a novel method with minimal intervention, we are looking forward to developing and evaluating this method in larger studies. IIranian Registry of Clinical Trials. Registered 25 May 2019, IRCT20190228042868N1 .
Sections du résumé
BACKGROUND
Most premature and very low birthweight infants cannot tolerate breast milk feeding in the first few days of life and are deprived of its benefits. This study evaluates the clinical outcomes of administering breast milk cell fractions to neonates with a birthweight of ≤1800 g.
METHODS
We conducted a randomized controlled trial on 156 infants in the neonatal intensive care unit of Mahdieh Maternity Hospital in Tehran, Iran, from May 2019 to April 2020. All neonates with a birthweight ≤1800 g were enrolled and divided into intervention and control groups using stratified block randomization. Neonates in the intervention group received the extracted breast milk cell fractions (BMCFs) of their own mother's milk after being centrifuged in the first 6 to 12 h after birth. The control group received routine care, and breastfeeding was started as soon as tolerated in both groups. Study outcomes were necrotizing enterocolitis (NEC), death, and in-hospital complications.
RESULTS
We divided participants into two groups: 75 neonates in the intervention group and 81 neonates in the control group. The mean birthweight of neonates was 1390.1 ± 314.4 g, and 19 (12.2%) neonates deceased during their in-hospital stay. The incidence of NEC was similar in both groups. After adjustment for possible confounders in the multivariable model, receiving BMCFs were independently associated with lower in-hospital mortality (5 [26.3%] vs. 70 (51.1%]; odds ratio (OR): 0.24; 95% confidence interval [CI] 0.07, 0.86). Also, in a subgroup analysis of neonates with birthweight less than 1500 g, in-hospital mortality was significantly lower in the intervention group (4 [9.5%] vs. 13 [30.2%]; OR: 0.24; 95% CI 0.07, 0.82). There were no differences in major complications such as bronchopulmonary dysplasia and retinopathy of prematurity between the two groups. No adverse effects occurred.
CONCLUSIONS
Our research demonstrated a significantly lower mortality rate in neonates (with a birthweight of ≤1800 g) who received breast milk cell fractions on the first day of life. Since this is a novel method with minimal intervention, we are looking forward to developing and evaluating this method in larger studies.
TRIAL REGISTRATION
IIranian Registry of Clinical Trials. Registered 25 May 2019, IRCT20190228042868N1 .
Identifiants
pubmed: 34425828
doi: 10.1186/s13006-021-00405-0
pii: 10.1186/s13006-021-00405-0
pmc: PMC8383348
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
63Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021. The Author(s).
Références
Mazzocchi A, Giannì ML, Morniroli D, Leone L, Roggero P, Agostoni C, et al. Hormones in breast milk and effect on infants' growth: a systematic review. Nutrients. 2019;11(8):1845. https://doi.org/10.3390/nu11081845 .
doi: 10.3390/nu11081845
Lönnerdal B. Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr. 2003;77(6):1537s–43s.
doi: 10.1093/ajcn/77.6.1537S
Yamakawa M, Yorifuji T, Kato T, Inoue S, Tokinobu A, Tsuda T, et al. Long-term effects of breastfeeding on children's hospitalization for respiratory tract infections and diarrhea in early childhood in Japan. Matern Child Health J. 2015;19(9):1956–65. https://doi.org/10.1007/s10995-015-1703-4 .
doi: 10.1007/s10995-015-1703-4
Witkowska-Zimny M, Kaminska-El-Hassan E. Cells of human breast milk. Cell Mol Biol Lett. 2017;22(1):11. https://doi.org/10.1186/s11658-017-0042-4 .
doi: 10.1186/s11658-017-0042-4
Hassiotou F, Hepworth AR, Metzger P, Tat Lai C, Trengove N, Hartmann PE, et al. Maternal and infant infections stimulate a rapid leukocyte response in breastmilk. Clin Transl Immunol. 2013;2(4):e3. https://doi.org/10.1038/cti.2013.1 .
doi: 10.1038/cti.2013.1
Serfass RE, Reddy MB. Breast milk fractions solubilize Fe(III) and enhance iron flux across Caco-2 cells. J Nutr. 2003;133(2):449–55. https://doi.org/10.1093/jn/133.2.449 .
doi: 10.1093/jn/133.2.449
Li W, Hosseinian FS, Tsopmo A, Friel JK, Beta T. Evaluation of antioxidant capacity and aroma quality of breast milk. Nutrition. 2009;25(1):105–14. https://doi.org/10.1016/j.nut.2008.07.017 .
doi: 10.1016/j.nut.2008.07.017
Aycicek A, Erel O, Kocyigit A, Selek S, Demirkol MR. Breast milk provides better antioxidant power than does formula. Nutrition. 2006;22(6):616–9. https://doi.org/10.1016/j.nut.2005.12.011 .
doi: 10.1016/j.nut.2005.12.011
Xavier AM, Rai K, Hegde AM. Total antioxidant concentrations of breastmilk--an eye-opener to the negligent. J Health Popul Nutr. 2011;29(6):605–11.
Modi M, Ramji S, Jain A, Kumar P, Gupta N. Early aggressive enteral feeding in neonates weighing 750-1250 grams: a randomized controlled trial. Indian Pediatr. 2019;56(4):294–8. https://doi.org/10.1007/s13312-019-1517-3 .
doi: 10.1007/s13312-019-1517-3
Fontana C, Menis C, Pesenti N, Passera S, Liotto N, Mosca F, et al. Effects of early intervention on feeding behavior in preterm infants: a randomized controlled trial. Early Hum Dev. 2018;121:15–20. https://doi.org/10.1016/j.earlhumdev.2018.04.016 .
doi: 10.1016/j.earlhumdev.2018.04.016
Salas AA, Li P, Parks K, Lal CV, Martin CR, Carlo WA. Early progressive feeding in extremely preterm infants: a randomized trial. Am J Clin Nutr. 2018;107(3):365–70. https://doi.org/10.1093/ajcn/nqy012 .
doi: 10.1093/ajcn/nqy012
Maffei D, Brewer M, Codipilly C, Weinberger B, Schanler RJ. Early oral colostrum administration in preterm infants. J Perinatol. 2020;40(2):284–7. https://doi.org/10.1038/s41372-019-0556-x .
doi: 10.1038/s41372-019-0556-x
Kwok TC, Dorling J, Gale C. Early enteral feeding in preterm infants. Semin Perinatol. 2019;43(7):151159. https://doi.org/10.1053/j.semperi.2019.06.007 .
doi: 10.1053/j.semperi.2019.06.007
Vass RA, Kemeny A, Dergez T, Ertl T, Reglodi D, Jungling A, et al. Distribution of bioactive factors in human milk samples. Int Breastfeed J. 2019;14(1):9. https://doi.org/10.1186/s13006-019-0203-3 .
doi: 10.1186/s13006-019-0203-3
Hassiotou F, Hartmann PE. At the dawn of a new discovery: the potential of breast milk stem cells. Adv Nutr. 2014;5(6):770–8. https://doi.org/10.3945/an.114.006924 .
doi: 10.3945/an.114.006924
Patki S, Kadam S, Chandra V, Bhonde R. Human breast milk is a rich source of multipotent mesenchymal stem cells. Hum Cell. 2010;23(2):35–40. https://doi.org/10.1111/j.1749-0774.2010.00083.x .
doi: 10.1111/j.1749-0774.2010.00083.x
Hosseini SM, Talaei-Khozani T, Sani M, Owrangi B. Differentiation of human breast-milk stem cells to neural stem cells and neurons. Neurol Res Int. 2014;2014:807896.
doi: 10.1155/2014/807896
Twigger AJ, Hodgetts S, Filgueira L, Hartmann PE, Hassiotou F. From breast milk to brains: the potential of stem cells in human milk. J Hum Lact. 2013;29(2):136–9. https://doi.org/10.1177/0890334413475528 .
doi: 10.1177/0890334413475528
Gregory KE, Deforge CE, Natale KM, Phillips M, Van Marter LJ. Necrotizing enterocolitis in the premature infant: neonatal nursing assessment, disease pathogenesis, and clinical presentation. Adv Neonatal Care. 2011;11(3):155–64. https://doi.org/10.1097/ANC.0b013e31821baaf4 .
doi: 10.1097/ANC.0b013e31821baaf4
Gomez Pomar E, Concina VA, Samide A, Westgate PM, Bada HS. Bronchopulmonary dysplasia: comparison between the two most used diagnostic criteria. Front Pediatr. 2018;6:397. https://doi.org/10.3389/fped.2018.00397 .
doi: 10.3389/fped.2018.00397
Prematurity ICftCoRo: The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123(7):991–9. https://doi.org/10.1001/archopht.123.7.99 .
Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al. Neonatal outcomes of extremely preterm infants from the NICHD neonatal research network. Pediatrics. 2010;126(3):443–56. https://doi.org/10.1542/peds.2009-2959 .
doi: 10.1542/peds.2009-2959
Wang H, Chow SC. Sample size calculation for comparing proportions. Wiley Encyclopedia of Clinical Trials 2007. https://doi.org/10.1002/9780471462422.eoct005 .
Efird J. Blocked randomization with randomly selected block sizes. Int J Environ Res Public Health. 2011;8(1):15–20. https://doi.org/10.3390/ijerph8010015 .
doi: 10.3390/ijerph8010015
Shiels MS, Chernyavskiy P, Anderson WF, Best AF, Haozous EA, Hartge P, et al. Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data. Lancet. 2017;389(10073):1043–54. https://doi.org/10.1016/S0140-6736(17)30187-3 .
doi: 10.1016/S0140-6736(17)30187-3
Kuziga F, Adoke Y, Wanyenze RK. Prevalence and factors associated with anaemia among children aged 6 to 59 months in Namutumba district, Uganda: a cross- sectional study. BMC Pediatr. 2017;17:25.
doi: 10.1186/s12887-017-0782-3
Indumathi S, Dhanasekaran M, Rajkumar JS, Sudarsanam D. Exploring the stem cell and non-stem cell constituents of human breast milk. Cytotechnology. 2013;65(3):385–93. https://doi.org/10.1007/s10616-012-9492-8 .
doi: 10.1007/s10616-012-9492-8
Abd Allah SH, Shalaby SM, El-Shal AS, El Nabtety SM, Khamis T, Abd El Rhman SA, et al. Breast milk MSCs: an explanation of tissue growth and maturation of offspring. IUBMB Life. 2016;68(12):935–42. https://doi.org/10.1002/iub.1573 .
doi: 10.1002/iub.1573